Vincent Hautefeuille

Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

Thierry Conroy, Florence Castan, Anthony Lopez et al. · JAMA Oncology · 2022 · 324 citations · Full text

Medicine, Oncology, Surgery +14

Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)

Astrid Lièvre, Anthony Turpin, Isabelle Ray‐Coquard et al. · European Journal of Cancer · 2020 · 164 citations · Full text

Medicine, Infectious Diseases, Oncology +14

Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort

Thomas Walter, David Tougeron, Éric Baudin et al. · European Journal of Cancer · 2017 · 112 citations

Medicine, Oncology, Pathology +14

Efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient advanced pancreatic adenocarcinoma: an AGEO European Cohort

Lina Sayah, Kathrin Heinrich, Volker Kunzmann et al. · European Journal of Cancer · 2023 · 86 citations · Full text

Life Sciences, Immunology, Oncology +17

Prognosis and chemosensitivity of deficient MMR phenotype in patients with metastatic colorectal cancer: An AGEO retrospective multicenter study

David Tougeron, Benjamin Sueur, Aziz Zaanan et al. · International Journal of Cancer · 2020 · 77 citations · Full text

Medicine, Biostatistics, Oncology +15